Liquid Biopsy Testing for Cancer Achieves Milestone

In celebration of National Cancer Prevention Day , Anpac Bio has announced that their cancer differentiation analysis (CDA) liquid biopsy test is now capable of detecting 26 different cancers from a single blood test.With research validation from over 60,000 cases, Anpac Bio’s CDA test has demonstrated a sensitivity and specificity rate of 75% to 90%. According to the company, the test generates fewer false positives, costs less than traditional testing, and returns results within minutes